Integration of Biomechanical and Biological Characterization in the Development of Porous Poly(caprolactone)-Based Membranes for Abdominal Wall Hernia Treatment

Table 3

Crystallization temperature and enthalpy of PCL and PEG phases as a function of blend composition measured from the DSC cooling scan (performed at 10°C/min); melting temperature and enthalpy of PCL and PEG phases as a function of blend composition measured from the second heating DSC scan (performed at 10°C/min).

Samples	Cooling cycle						Second heating cycle
	(°C)	value	(J/g)	value	(°C)	(J/g)	(°C)	value	(°C)	(J/g)	value
PCL	26.1 ± 0.3	—	54.5 ± 2.9	—	—	—	57.4 ± 0.3	—	—	54.2 ± 1.9	—
PCL/PEG1 70/30	22.8 ± 0.7	<0.0001	49.9 ± 1.8	<0.0001	1.6 ± 0.1; 35.5 ± 0.4	8.9 ± 0.3; Overlapped	56.9 ± 0.1	<0.0001	62.7 ± 0.1	81.1 ± 0.1	<0.0001
PCL7-1i	26.4 ± 0.7		57.9 ± 0.8		—	—	57.5 ± 0.1		—	59.8 ± 0.3
PCL/PEG1 60/40	23.0 ± 0.4	<0.0001	22.1 ± 3.3	<0.0001	2.4 ± 0.2; 39.1 ± 1.4	0.9 ± 0.5; 36.3 ± 4.4	56.2 ± 0.2	0.0003	63.3 ± 0.2	90.9 ± 3.2	<0.0001
PCL6-1i	28.6 ± 0.2		57.6 ± 0.7		—	—	57.4 ± 0.4		—	59.0 ± 2.0
PEG1	—	—	—	—	41.6 ± 0.5	160.9 ± 3.6	—	—	65.6 ± 0.4	164.7 ± 3.3	—
PCL/PEG2 70/30	25.6 ± 0.1	<0.0001	34.9 ± 1.9	<0.0001	1.2 ± 0.3; Not detected	10.6 ± 3.4; Not detected	56.9 ± 0.4	0.0266	63.8 ± 0.3	75.1 ± 1.2	<0.0001
PCL7-2i	27.5 ± 0.1		57.8 ± 0.8		—	—	57.4 ± 0.1		—	58.2 ± 2.5
PCL/PEG2 60/40	22.8 ± 0.8	<0.0001	23.8 ± 0.8	<0.0001	1.4 ± 0.4; 40.0 ± 0.7	9.5 ± 0.3; 30.1 ± 2.5	56.6 ± 0.3	0.0029	64.5 ± 0.2	83.7 ± 1.9	<0.0001
PCL6-2i	26.8 ± 0.1		58.2 ± 0.6		—	—	57.4 ± 0.3		—	55.9 ± 1.1
PEG2	—	—	—	—	41.9 ± 0.7	148.1 ± 3.2	—	—	66.5 ± 0.1	148.7 ± 3.3	—